Sumitomo Mitsui Trust Holdings, Inc. Exact Sciences Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$156 Billion
Q2 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 173,136 shares of EXAS stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

173,136

Previous 567,506 69.49%

Holding current value

$10.6 Million

Previous $24.6 Million 62.55%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$40.31 - $58.08 $15.9 Million - $22.9 Million	-394,370 Reduced 69.49%	173,136 $9.2 Million
Q1 2025 Apr 25, 2025	SELL	$43.04 - $58.51 $16.2 Million - $22.1 Million	-377,455 Reduced 39.94%	567,506 $24.6 Million
Q4 2024 Jan 28, 2025	SELL	$49.33 - $71.97 $5.18 Million - $7.55 Million	-104,974 Reduced 10.0%	944,961 $53.1 Million
Q3 2024 Nov 05, 2024	SELL	$42.43 - $70.83 $3.94 Million - $6.58 Million	-92,841 Reduced 8.12%	1,049,935 $71.5 Million
Q2 2024 Jul 19, 2024	SELL	$41.33 - $74.26 $34.3 Million - $61.7 Million	-830,816 Reduced 42.1%	1,142,776 $48.3 Million
Q1 2024 Apr 19, 2024	SELL	$56.27 - $73.77 $13.3 Million - $17.4 Million	-235,658 Reduced 10.67%	1,973,592 $136 Million
Q4 2023 Jan 30, 2024	SELL	$59.06 - $75.72 $11.7 Million - $15 Million	-198,252 Reduced 8.23%	2,209,250 $163 Million
Q3 2023 Oct 30, 2023	SELL	$65.94 - $99.04 $15.7 Million - $23.5 Million	-237,348 Reduced 8.97%	2,407,502 $164 Million
Q2 2023 Jul 31, 2023	SELL	$62.68 - $95.05 $71.1 Million - $108 Million	-1,133,545 Reduced 30.0%	2,644,850 $248 Million
Q1 2023 Apr 27, 2023	SELL	$47.19 - $70.77 $74.9 Million - $112 Million	-1,586,204 Reduced 29.57%	3,778,395 $256 Million
Q4 2022 Jan 30, 2023	SELL	$30.35 - $53.15 $35 Million - $61.3 Million	-1,152,546 Reduced 17.68%	5,364,599 $266 Million
Q3 2022 Oct 21, 2022	BUY	$31.97 - $49.37 $22.7 Million - $35 Million	709,540 Added 12.22%	6,517,145 $212 Million
Q2 2022 Jul 26, 2022	BUY	$35.61 - $76.23 $6.28 Million - $13.4 Million	176,261 Added 3.13%	5,807,605 $229 Million
Q1 2022 Apr 27, 2022	SELL	$57.56 - $82.54 $14.5 Million - $20.8 Million	-251,836 Reduced 4.28%	5,631,344 $394 Million
Q4 2021 Feb 02, 2022	BUY	$72.5 - $100.68 $87.3 Million - $121 Million	1,203,450 Added 25.72%	5,883,180 $458 Million
Q3 2021 Oct 25, 2021	BUY	$90.24 - $124.05 $84.5 Million - $116 Million	936,245 Added 25.01%	4,679,730 $447 Million
Q2 2021 Aug 02, 2021	BUY	$93.66 - $139.27 $100 Million - $149 Million	1,067,298 Added 39.88%	3,743,485 $465 Million
Q1 2021 Apr 30, 2021	BUY	$116.57 - $155.01 $97.6 Million - $130 Million	836,874 Added 45.5%	2,676,187 $353 Million
Q4 2020 Feb 05, 2021	BUY	$99.61 - $142.12 $115 Million - $164 Million	1,156,192 Added 169.25%	1,839,313 $244 Million
Q3 2020 Oct 30, 2020	BUY	$72.92 - $102.01 $6.94 Million - $9.71 Million	95,224 Added 16.2%	683,121 $69.6 Million
Q2 2020 Jul 27, 2020	SELL	$55.75 - $92.75 $26,091 - $43,407	-468 Reduced 0.08%	587,897 $51.1 Million
Q1 2020 Apr 27, 2020	BUY	$37.9 - $104.44 $952,730 - $2.63 Million	25,138 Added 4.46%	588,365 $34.1 Million
Q4 2019 Jan 31, 2020	BUY	$77.66 - $99.74 $6.19 Million - $7.95 Million	79,728 Added 16.49%	563,227 $52.1 Million
Q3 2019 Oct 31, 2019	SELL	$90.37 - $122.49 $3.13 Million - $4.24 Million	-34,632 Reduced 6.68%	483,499 $43.7 Million
Q2 2019 Jul 29, 2019	BUY	$89.51 - $118.04 $46.4 Million - $61.2 Million	518,131 New	518,131 $61.2 Million

Others Institutions Holding EXAS

# of Institutions

647

Shares Held

156M

Call Options Held

1.43M

Put Options Held

2.3M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.8B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Exact Sciences Corp Transaction History